Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Sepsis drug also protects brain cells

19.02.2004


A compound currently used to treat patients with severe sepsis also protects brain cells in an unexpected way, say researchers at the University of Rochester Medical Center in the Feb. 19 issue of the journal Neuron.



Doctors currently use a modified version of activated protein C or APC to reduce inflammation or increase blood flow in patients with severe sepsis, and last year neuroscientist Berislav Zlokovic, M.D., Ph.D., led a team that showed that the compound also protects the cells that are vital to supply blood to the brain. In the latest paper, Zlokovic and colleagues show that the compound also directly protects vital brain cells known as neurons.

While several compounds have been shown in the laboratory to protect neurons, the latest finding is of special interest for a few reasons, says Zlokovic, who heads the Frank P. Smith Laboratories for Neurosurgical Research.


"This is a compound that’s naturally present in your body, and it’s already being used to treat people – it’s not a chemical tucked away in a laboratory," he says. In addition, one of the biggest side effects of APC is increased bleeding, and the team showed that the protection APC bestows is separate from its ability to increase blood flow and reduce inflammation. The findings open the possibility of creating a new compound that would keep brain cells healthy but without causing major side effects like increased bleeding.

Working closely with Zlokovic, Huang Guo, research assistant professor of Neurosurgery, and Dong Liu, post-doctoral fellow, showed that APC protects neurons by activating receptors known as PAR-1 and PAR-3. They showed that the compound helps protect against a variety of causes of "apoptosis," or programmed cell death, one of the major ways we all lose brain cells.

Preventing neurons from killing themselves – committing apoptosis – when they shouldn’t is a broad goal of researchers. Apoptosis often happens when cells detect danger and go into a state of hyper-signaling, much as a panicked airline crew might react as their plane plunges toward the ocean. In the brain, the process results in high levels of chemicals that kill cells and are responsible for a great deal of brain damage from stroke, brain injury, and Alzheimer’s and Huntington’s diseases.

The team showed that APC protects brain cells from such apoptosis brought about by a variety of causes, as well as apoptosis by a chemical known as staurosporine.

"This opens the door to a new class of anti-apoptotic agents based on blood factors that act directly on neurons" says Zlokovic, who is professor of Neurosurgery. "Regardless of the cause of neuronal apoptosis, neurons are able to survive in the presence of APC."

In a paper last year in Nature Medicine, the team showed that APC protects endothelial cells in the brain – the cells that form blood vessels – by preventing apoptosis of those cells. In the current paper, the team showed both in the laboratory and in mice that APC saved about 70 percent of the neurons that would have otherwise died. The benefit disappears if either PAR-1 or PAR-3 aren’t working correctly.

In addition to Zlokovic, Guo and Liu, the team from Rochester included Tong Cheng, research assistant professor; technician Rae Insalaco; and Harris Gelbard, professor of neurology. The team also included protein chemist John Griffin and Jose Fernandez of Scripps Research Institute in La Jolla, Calif.


The work was funded by the National Heart, Lung, and Blood Institute and was done in collaboration with Socratech Laboratories, a Rochester start-up company founded by Zlokovic.

Tom Rickey | EurekAlert!
Further information:
http://www.urmc.rochester.edu/

More articles from Health and Medicine:

nachricht Satellites, airport visibility readings shed light on troops' exposure to air pollution
09.12.2016 | Veterans Affairs Research Communications

nachricht Oxygen can wake up dormant bacteria for antibiotic attacks
08.12.2016 | Penn State

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>